Maynard Um
-
-
-
-
-
-
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $656 at UBS
-
-
-
-
-
-
-
Madrigal Pharma (MDGL) Misses Q4 EPS by 197c
-
-
-
-
-
-
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $900 as Piper Sandler Recommends Buy
-
-
-
-
-
-
-
Madrigal Pharmaceuticals (MDGL) PT Raised to $510 at Leerink Partners
-
-
-
-
-
-
-
Truist Securities Starts Madrigal Pharmaceuticals (MDGL) at Buy
-
-
-
-
-
-
-
Piper Sandler: 'We Remain Bullish on Madrigal Pharmaceuticals (MDGL)'
-
-
-
-
-
-
-
Madrigal Pharma (MDGL) Tops Q2 EPS by $1.73, Beats on Revenue
-
401,638 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

